CVS Health Corporation $CVS Shares Sold by Alps Advisors Inc.

Alps Advisors Inc. decreased its holdings in CVS Health Corporation (NYSE:CVS) by 6.1% during the 3rd quarter, HoldingsChannel reports. The fund owned 327,214 shares of the pharmacy operator’s stock after selling 21,159 shares during the quarter. Alps Advisors Inc.’s holdings in CVS Health were worth $24,669,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. SOA Wealth Advisors LLC. boosted its stake in CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares during the last quarter. Symmetry Partners LLC raised its stake in shares of CVS Health by 2.5% in the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. HF Advisory Group LLC grew its stake in CVS Health by 2.9% in the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after purchasing an additional 145 shares in the last quarter. Finally, United Asset Strategies Inc. increased its holdings in CVS Health by 1.8% in the third quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock valued at $667,000 after buying an additional 154 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent research reports. Robert W. Baird boosted their target price on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Leerink Partners increased their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Morgan Stanley lifted their target price on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Argus dropped their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Finally, Wolfe Research raised their price target on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, December 8th. Nineteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Price Performance

CVS stock opened at $78.38 on Friday. The firm has a 50-day moving average of $78.62 and a two-hundred day moving average of $75.65. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a one year low of $53.36 and a one year high of $85.15. The firm has a market capitalization of $99.50 billion, a PE ratio of 206.27, a P/E/G ratio of 0.72 and a beta of 0.50.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio is currently 700.00%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.